Statement of Principles concerning malignant neoplasm of the larynx No. 1 of 2006

Administered by Department of Veterans' Affairs

Legislation au F2006L00613 Not in force Legislative Instrument

Legislation content

 

 

 

 

 

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 1 of 2006

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (‘the Authority’), under subsection 196B(8) of the Veterans’ Entitlements Act 1986 (‘the VEA’) revokes Instrument No. 27 of 1995 of 20 February 1995; Instrument No. 155 of 1995 of 13 April 1995; Instrument No. 151 of 1996 of 26 September 1996; and Instrument No. 193 of 1996 of 9 December 1996, each of which were determined under subsection 196B(2) of the VEA concerning malignant neoplasm of the larynx and death from malignant neoplasm of the larynx.

 

2.             The Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the larynx and death from malignant neoplasm of the larynx can be related to particular kinds of service. The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles, Instrument No. 1 of 2006 concerning malignant neoplasm of the larynx.  This Instrument will in effect replace the revoked Statements of Principles.

 

3.             The provisions of the Military Rehabilitation and Compensation Act 2004 (‘the MRCA’) relating to claims for compensation commenced on 1 July 2004.  Claims under section 319 of the MRCA for acceptance of liability for a service injury sustained, a service disease contracted or service death on or after 1 July 2004 are determined by the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.

 

4.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

 

before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the larynx or death from malignant neoplasm of larynx, with the circumstances of that service.

 

5.             This new instrument results from an investigation notified by the Authority in the Government Notices Gazette of 16 July 2003 concerning malignant neoplasm of the larynx in accordance with section 196G of the Act. The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

 

6.             The contents of the new Instrument are in similar terms as the revoked Instruments.  Comparing the new and the revoked Instruments, the differences include:

 

  • adopting the latest revised Instrument format, which commenced in 2005;
  • deleting the ICD code from the Instrument header;
  • revising the definition of ‘malignant neoplasm of the larynx’ in clause 3;
  • rewording factor 6(a) relating to smoking;
  • rewording factor 6(b) relating to “being in an atmosphere with a visible tobacco smoke haze”;
  • rewording factor 6(c) relating to “being exposed to mustard gas”;
  • rewording factor 6(d) relating to “inhaling respirable asbestos fibres”;
  • including new factor 6(e) concerning “inhaling smoke from the combustion of biomass or fossil fuels”;
  • rewording factor 6(f) relating to “ drinking at least 250 kilograms of alcohol”;
  • rewording factor 6(g) relating to being on land in Vietnam or at sea in Vietnamese waters to reflect the latest wording for this factor;
  • rewording factor 6(h) relating to “inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)” to reflect the latest wording for this factor;
  • revising the definition of ‘pack years of cigarettes, or the equivalent thereof in other tobacco products’; ‘respirable asbestos fibers’; ‘relevant service’; and ‘ICD-10-AM code’ in clause 9;
  • including new definitions of ‘alcohol’; an enclosed space’; being on land in Vietnam or at sea in Vietnamese waters’; ‘death from malignant neoplasm of the larynx’; ‘estuarine Vietnamese waters’; ‘inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD)’, and ‘terminal event’ in clause 9; and
  • specifying a date of effect for the Instrument in clause 11.

 

7.             Further changes to the format of the Instrument reflect the commencement of the MRCA and clarify that pursuant to subsection 196B(3A) of the VEA, the Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

 

8.             Prior to determining this instrument, the Authority advertised its intention to undertake an investigation in relation to malignant neoplasm of the larynx in the Government Notices Gazettes of 16 July 2003, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. Two submissions were received for consideration by the Authority.

 

9.             Following the commencement of the MRCA, the Authority published a “Further Notice of Investigations” in the Government Notices Gazette of 14 July 2004, extending the closing date for submissions in relation to the above mentioned investigation until 10 September 2004. The Authority again invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA (who include persons eligible to make a claim under the MRCA), as well as the Military Rehabilitation and Compensation Commission and any person having expertise in the field.

 

10.         The determining of this new instrument finalises the investigation in relation to malignant neoplasm of the larynx as advertised in the Government Notices Gazettes of 16 July 2003.

 

11.         A list of references relating to the above condition is available, on written request, from the Repatriation Medical Authority Secretariat.

Overview

The Repatriation Medical Authority Instrument No. 1 of 2006, enacted in 2006, addresses the need for updated medical-scientific evidence concerning the relationship between malignant neoplasm of the larynx and specific military service types. This legislative instrument was introduced by the Repatriation Medical Authority under subsection 196B(8) of the Veterans’ Entitlements Act 1986 and is intended to replace previous revoked instruments related to malignant neoplasm of the larynx. It aligns with the policy objective of ensuring that claims for compensation, particularly those concerning service injuries or diseases, are assessed based on the most current medical evidence available. This instrument sets out the factors that must exist to connect malignant neoplasm of the larynx with particular military services, facilitating the acceptance of liability for claims under the Military Rehabilitation and Compensation Act 2004. The Authority has undertaken an investigation to review the sound medical-scientific evidence, which led to the creation of this updated Statement of Principles, replacing previous revoked instruments and clarifying the criteria for claims concerning malignant neoplasm of the larynx.

Scope and Application

The Repatriation Medical Authority Instrument No. 1 of 2006, concerning malignant neoplasm of the larynx, applies to veterans, service personnel, and their dependants who may have sustained malignant neoplasm of the larynx or died from such conditions during or as a result of their service. This instrument replaces previous revoked instruments and is applicable to service rendered under various categories such as operational, peacekeeping, hazardous, warlike, and non-warlike service, as defined under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The instrument outlines the minimum factors that must be present and related to the service conditions for a claim to be considered valid. It is issued under the authority of the Veterans’ Entitlements Act 1986 and applies nationally across Australia. The Authority's determination of this Statement of Principles allows for claims for compensation for conditions sustained or contracted on or after 1 July 2004 to be assessed by the Military Rehabilitation and Compensation Commission in accordance with the new instrument. The instrument also clarifies that it serves the purposes of both the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004.

Key Provisions

The Repatriation Medical Authority, under section 196B(8) of the Veterans’ Entitlements Act 1986, has issued Instrument No. 1 of 2006, revoking previous instruments related to malignant neoplasm of the larynx and death from such neoplasm. This new Instrument, which sets out the Statement of Principles, establishes the medical criteria connecting malignant neoplasm of the larynx or death from such neoplasm with specific types of military service. These types of service include operational service, peacekeeping service, hazardous service, warlike service, and non-warlike service as defined under the Veterans’ Entitlements Act and the Military Rehabilitation and Compensation Act 2004. The new Statement of Principles delineates the minimum factors that must exist, and which of those factors must be related to the relevant types of military service, to establish a reasonable hypothesis connecting malignant neoplasm of the larynx or death from such neoplasm with the service rendered. This Statement of Principles is determined by the Military Rehabilitation and Compensation Commission for claims of compensation for injuries, diseases, or deaths occurring on or after 1 July 2004. The Authority has made several revisions to the previous Instruments, including updates to definitions and factors related to exposure to various substances and environments, and the adoption of a new format to align with the commencement of the Military Rehabilitation and Compensation Act. Parties governed by the Veterans’ Entitlements Act and the Military Rehabilitation and Compensation Act must adhere to the criteria outlined in the new Statement of Principles when assessing claims related to malignant neoplasm of the larynx. Claimants must provide evidence that supports the connection between their condition and the specified military service factors, in accordance with the requirements of the Instrument. The Authority, in determining the Statement of Principles, has considered submissions from relevant organisations and experts, ensuring that the criteria are based on sound medical-scientific evidence. Breaches of the requirements set out in the Statement of Principles may result in claims being denied if the necessary criteria are not met. There are no specific criminal or civil penalties outlined for non-compliance with the Statement of Principles itself; however, fraudulent claims or misrepresentation of facts to obtain benefits may incur penalties under the relevant Acts. The maximum penalties for such offences can include substantial fines and imprisonment, depending on the severity of the fraud or misrepresentation.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Licensing & Registration
Catchwords
malignant neoplasm of the larynx

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.